Evidence map›Paper›PMID 39771369›Full record

ArticlePolymers2024

Research on the Mechanical Properties of EPS Lightweight Soil Mixed with Fly Ash.

Lifang Mei, Yiwen Huang, Dali Xiang

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lifang MeiSchool of Civil Engineering, Architectural and Environment, Hubei University of Technology, Wuhan 430068, China.
Yiwen HuangSchool of Civil Engineering, Architectural and Environment, Hubei University of Technology, Wuhan 430068, China.ORCID 0009-0001-3827-0773
Dali XiangSchool of Civil Engineering, Architectural and Environment, Hubei University of Technology, Wuhan 430068, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expanded polystyrene (EPS) bead-lightweight soil composites are a new type of artificial geotechnical material with low density and high strength. We applied EPS bead-lightweight soil in this project, replacing partial cement with fly ash to reduce construction costs. EPS beads were used as a lightweight material and cement and fly ash as curing agents in the raw soil were used to make EPS lightweight soil mixed with fly ash. The EPS bead proportions were 0.5%, 1%, 1.5%, and 2%; the total curing agent contents were 10%, 15%, 20%, and 25%; and the proportions of fly ash replacing cement were 0%, 15%, 30%, 45%, and 60%, respectively. Unconfined compressive strength (UCS) and scanning electron microscopy (SEM) tests were conducted. The results showed that the EPS content, total curing agent content, and proportion of fly ash replacing cement had a significant impact on the UCS of the lightweight soil. This decreased with an increase in EPS content and decrease in total curing agent content and decreased with increased proportions of fly ash replacing cement. When the proportion of fly ash replacing cement was not too high, the strength of the lightweight soil decreased less, and its performance still met engineering needs. At the same time, the soil can also consume fly ash and reduce environmental pollution. EPS lightweight soil mixed with fly ash still has advantages, and it is recommended to keep the proportion of fly ash replacing cement less than 30%. The failure patterns for lightweight soil mainly include splitting failure, oblique shear failure, and bulging failure, which are related to the material mix ratio.

Indexed as

EPS beadsfly ashlightweight soilmechanical propertiesmicro

Identifiers

PMID39771369
PMCPMC11678610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.